Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001601830-24-000220
Filing Date
2024-11-22
Accepted
2024-11-22 18:25:19
Documents
2
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1732317911.html 3  
1 FORM 3 wk-form3_1732317911.xml 3 1591
2 EX-24.POA michorpoa.txt EX-24.POA 2042
  Complete submission text file 0001601830-24-000220.txt   5180
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 S. RIO GRANDE ST. SALT LAKE CITY UT 84101
Business Address
Michor Franziska (Reporting) CIK: 0002045159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 241491295